CE-MS Solutions Enabling Next-Generation Therapeutics
Elucidating the metabolic or signaling pathways for new disease indications often requires sampling from only a few cells. New types of protein therapeutics, oligonucleotide therapies, viral gene therapies and cell therapies keep expanding in their level of complexity and level of required characterization. In short, more types of biomolecules in smaller amounts must be analyzed in greater detail.
Download this info kit to discover solutions that:
- Can analyze compounds with positive or negative polarity
- Provide easy-to-use kits for a variety of protein workflows
- Have superior separation for a wide variety of biomolecules
